Maggiolo F - Search Results

1

Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2).

Maggiolo F, Gianotti N, Comi L, Di Filippo E, Fumagalli L, Nozza S, Galli L, Valenti D, Rizzi M, Castagna A. Maggiolo F, et al. J Antimicrob Chemother. 2020 May 1;75(5):1332-1337. doi: 10.1093/jac/dkaa018. J Antimicrob Chemother. 2020. PMID: 32129855 Clinical Trial.

2

Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.

Arici C, Ripamonti D, Ravasio V, Maggiolo F, Rizzi M, Finazzi MG, Suter F. Arici C, et al. Among authors: maggiolo f. Int J STD AIDS. 2001 Sep;12(9):573-81. doi: 10.1258/0956462011923741. Int J STD AIDS. 2001. PMID: 11516366

3

Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz.

Maggiolo F, Migliorino M, Maserati R, Pan A, Rizzi M, Provettoni G, Rizzi L, Suter F; Once Study Group. Maggiolo F, et al. Antivir Ther. 2001 Dec;6(4):249-53. Antivir Ther. 2001. PMID: 11878406

4

Resolution of lymphocytic interstitial pneumonia in a human immunodeficiency virus-infected adult following the start of highly active antiretroviral therapy.

Ripamonti D, Rizzi M, Maggiolo F, Arici C, Suter F. Ripamonti D, et al. Among authors: maggiolo f. Scand J Infect Dis. 2003;35(5):348-51. doi: 10.1080/00365540310012000. Scand J Infect Dis. 2003. PMID: 12875528

5

Switch strategies in patients on effective HAART.

Maggiolo F, Ripamonti D, Suter F. Maggiolo F, et al. J Antimicrob Chemother. 2005 Jun;55(6):821-3. doi: 10.1093/jac/dki119. Epub 2005 Apr 22. J Antimicrob Chemother. 2005. PMID: 15849261

6

Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).

Carosi G, Torti C, Andreoni M, Angarano G, Antinori A, Bonora S, Borderi M, Castagna A, Castelli F, Cauda R, Chiodo F, D'arminio-Monforte A, De Luca A, Di Perri G, Dianzani F, Filice G, Galli M, Lazzarin A, Maggiolo F, Maserati R, Mazzotta F, Moroni M, Perno CF, Vullo V. Carosi G, et al. Among authors: maggiolo f. J Antimicrob Chemother. 2006 Jun;57(6):1055-64. doi: 10.1093/jac/dkl113. Epub 2006 Apr 10. J Antimicrob Chemother. 2006. PMID: 16606637

7

Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohort.

Maggiolo F, Arici C, Airoldi M, Ripamonti D, Quinzan G, Gregis G, Ravasio V, Bombana E, Suter F. Maggiolo F, et al. J Antimicrob Chemother. 2007 Mar;59(3):569-72. doi: 10.1093/jac/dkl534. Epub 2007 Jan 25. J Antimicrob Chemother. 2007. PMID: 17255141

8

CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.

Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G; Italian MASTER Cohort. Torti C, et al. Among authors: maggiolo f. J Antimicrob Chemother. 2007 Jun;59(6):1141-7. doi: 10.1093/jac/dkm100. Epub 2007 Apr 13. J Antimicrob Chemother. 2007. PMID: 17434879

9

Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation.

Antinori A, Trotta MP, Lorenzini P, Torti C, Gianotti N, Maggiolo F, Ceccherini-Silberstein F, Nasto P, Castagna A, De Luca A, Mussini C, Andreoni M, Perno CF; GNOMO Study Group. Antinori A, et al. Among authors: maggiolo f. Antivir Ther. 2007;12(8):1175-83. Antivir Ther. 2007. PMID: 18240858

10

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.

Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P, Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa I.C.o.N.A the Icona Foundation Study Groups. Morsica G, et al. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592. J Acquir Immune Defic Syndr. 2009. PMID: 19590432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page